SMBT
ABBV icon

Southern Michigan Bank & Trust’s AbbVie ABBV Stock Holding History

Southern Michigan Bank & Trust’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.38M Sell
9,445
-92
-1% -$19.8K 0.84% 15
2026
Q1 		$2.07M Buy
+9,537
New +$2.12M 0.8% 14

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Southern Michigan Bank & Trust's ABBV Position: Q2 2026 in Review

Southern Michigan Bank & Trust reduced its AbbVie (ABBV) stake by 0.96% in Q2 2026, selling an estimated $19.8K and leaving 9,445 shares worth $2.38M. The position accounts for 0.84% of the portfolio, ranked #15.

Southern Michigan Bank & Trust first reported a position in ABBV in Q1 2026 and has held it in 2 quarters since. 4,063 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Southern Michigan Bank & Trust held 9,445 shares of AbbVie worth $2.38M as of Q2 2026.
  • Southern Michigan Bank & Trust sold 92 AbbVie shares in Q2 2026, an estimated $19.8K.
  • AbbVie made up 0.84% of Southern Michigan Bank & Trust's portfolio in Q2 2026, its #15 holding.
  • Southern Michigan Bank & Trust first reported a position in AbbVie in Q1 2026 and has held it in 2 quarters since.
  • 4,063 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Southern Michigan Bank & Trust's 13F filing for Q2 2026, filed 21 Jul 2026.